Cited by 171Suicide and Self-Harm StudiesTreatment of Major DepressionMental Health Treatment and Access

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Antidepressants' Black-Box Warning — 10 Years Later

Open access

Friedman, Richard A.·2014·New England Journal of Medicine

Open this paper in CoChat — free account Open PDF

Abstract

In 2004, the FDA issued a black-box warning linking antidepressants to an increased risk of suicidal thinking, feeling, and behavior in young people. But some worrisome trends suggest that the warning may inadvertently discourage appropriate treatment of depression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmp1408480

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study
Lu, C. Y., Zhang, F., Lakoma, M. D., Madden, J. M., Rusinak, D., Penfold, R. B., Simon, G. E., Ahmedani, B. K., Clarke, G. N., Hunkeler, E. M., et al. (2014) · BMJ · doi:10.1136/bmj.g3596 · Cited by 229
Suicide among adults aged 35-64 years--United States, 1999-2010.
Sullivan, E., Annest, J. L., Luo, F., Simon, T. R., & Dahlberg, L. L. (2013) · PubMed Central · Cited by 155
Persisting Decline in Depression Treatment After FDA Warnings
Libby, A. M., Orton, H. D., & Valuck, R. J. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.46 · Cited by 153
Spillover Effects on Treatment of Adult Depression in Primary Care After FDA Advisory on Risk of Pediatric Suicidality With SSRIs
Valuck, R. J., Libby, A. M., Orton, H. D., Morrato, E. H., Allen, R. R., & Baldessarini, R. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07010007 · Cited by 137
The FDA Warning on Antidepressants and Suicidality — Why the Controversy?
Stone, M. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1411138 · Cited by 45

Flagged first, then by citations

Show all 5 references

Research works printed but not linked: 1

2013, MMWR Morb Mortal Wkly Rep, 62, 321

Sorted by citations

Items 101–170 of 170

Insomnia During Late Life: Potential Pathways Toward Suicide Risk
Bishop, T. M., Titus, C. E., Lutz, J., & Pigeon, W. R. (2024) · Current Sleep Medicine Reports · doi:10.1007/s40675-024-00310-y · Cited by 1
“He Has a Gun and Wants to Kill Himself”
Botash, C. R. (2019) · Springer eBooks · doi:10.1007/978-3-030-03544-0_11 · Cited by 1
Psychopharmacology of Suicide
Limandri, B. J. (2019) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20191112-02 · Cited by 1
Trauma and Posttraumatic Stress in Transitional-Age Youth
Kletter, H., Trager, E., Kang, J., Friedman, M., & Reicherter, D. (2021) · Springer eBooks · doi:10.1007/978-3-030-62113-1_8 · Cited by 1
Depression management and pharmacoepigenetics
Walker, S. A., Su, A., & Kamath, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823039-8.00002-2 · Cited by 1
Brain science in American courts: the culpable neurotransmitters
Brewer, J. K. (2023) · Journal of Forensic Practice · doi:10.1108/jfp-05-2022-0028 · Cited by 1
US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeutics
Eadie, A. L., MacGregor, A., Wallach, J. D., Ross, J. S., & Herder, M. (2023) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2022-112005 · Cited by 1
Retrospective Evaluation of Drug-Drug Interactions With Erlotinib and Gefitinib Use in the Military Health System
Luong, T.-L. T. (2023) · Federal Practitioner · doi:10.12788/fp.0401 · Cited by 1
A Review of Psychopharmacology for the Management of Depression and Anxiety in Children and Adolescents
Cwynar, C. M. (2024) · Advances in Family Practice Nursing · doi:10.1016/j.yfpn.2024.01.018 · Cited by 1
Risk-aware restricted outcome learning for individualized treatment regimes of schizophrenia
Zhu, S., Shen, W., Fu, H., & Qu, A. (2024) · The Annals of Applied Statistics · doi:10.1214/23-aoas1836 · Cited by 1
Suicidality and psychotropic drugs: Another perspective
Price, L. H. (2025) · The Brown University Psychopharmacology Update · doi:10.1002/pu.31350 · Cited by 1
Primary care for depression before and during the COVID-19 pandemic: a retrospective pre–post study
Howard, M., Freeman, K., Hafid, S., Vanstone, M. G., Queenan, J. A., Aubrey-Bassler, K., Drummond, N., Nicholson, K., & Mangin, D. A. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-108681 · Cited by 1
Anxiety: a Primer for the Pediatrician
Lichtor, S. A., Afzal, K. I., Shapiro, J. B., Drossos, T., Radwan, K., Anam, S., & Connolly, S. D. (2018) · Current Treatment Options in Pediatrics · doi:10.1007/s40746-018-0114-3 · Cited by 1
Children and Adolescents With Suicidal Thoughts and Behaviors
Foster, C. E., Yegüez, C. E., & King, C. A. (2018) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190634841.013.35 · Cited by 1
Black-Box Warnings: Their Consequences and how We Should Approach Them
Balon, R. (2022) · Annals of Clinical Psychiatry · doi:10.12788/acp.0084 · Cited by 1
Antidepressant Medications and Suicide Risk: What Was the Impact of FDA Warning?
Serafini, G., Solano, P., & Amore, M. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_31
Pediatric Psychopharmacology: a Primer for the Treatment of Common Mental Health Conditions
Gleason, M. M. (2017) · Current Treatment Options in Pediatrics · doi:10.1007/s40746-017-0081-0
The Safety of Antidepressants
Giraldi, T. (2017) · Springer eBooks · doi:10.1007/978-3-319-57657-2_11
Thinking About (Completed) Suicide
Libeu, S., & Dinwiddie, S. H. (2017) · Psychiatric Annals · doi:10.3928/00485713-20170802-01
Medicolegal Considerations in Prescribing Psychiatric Medications to Youth
Ash, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-90350-7_9
Another Step Toward Clarifying the Benefits and Burdens of Selective Serotonin Reuptake Inhibitors
Wulsin, L. R. (2019) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000735
Délai d’action de la fluoxétine chez les enfants souffrant de dépression
Yan, T. D., & Goldman, R. D. (2019) · Europe PMC (PubMed Central)
Focus on pharmacotherapy for depression
Chesebro, J., Armes, K., & Peterson, K. (2019) · Nursing · doi:10.1097/01.nurse.0000604708.27955.43
The Suicide Epidemic in Youth and the FDA Black-Box Warning: Time to Reconsider
Nierenberg, A. A. (2020) · Psychiatric Annals · doi:10.3928/00485713-20191202-01
What Is Suicidal Behavior, and Can It Be Prevented?
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.002
“In my end is my beginning”
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.008
I Predict, Therefore I Cannot Be
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.009
Predicting the Unpredictable
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.010
The Dark Side of the Brain
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.004
Brief Review of Major Depressive Disorder for Primary Care Providers.
Jj, C., & Escalona, P. R. (2016) · Europe PMC (PubMed Central)
Protecting Youth in the Mental Health Service Settings.
Makini, G. K., Hishinuma, E. S., Guerrero, A. P. S., & Goebert, D. A. (2020) · PubMed Central
The Treatment of Suicide Risk
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.011
Images of the Suicidal Brain
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.007
Use of Medications in Suicide Prevention
Moutier, C. Y., Pisani, A. R., & Stahl, S. M. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108564618.009
I Think, Therefore I Do Not Want to Be
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.006
Basics of Psychopharmacological Management
Chan, E., Trier, K. A., & Chung, P. J. (2018) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610021357-23
From the Second Half of the Twentieth Century to the Early Twenty-First: The Psychopharmacologic Era
Fountoulakis, K. (2021) · Psychiatry · doi:10.1007/978-3-030-86541-2_11 · Cited by 1
Montale tra Eliot e Dante
de Rogatis, T. (1996) · Annali della Facoltà di Lettere e Filosofia
References
(2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.013
Colour Plates
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.015
Preface
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.001
Lethal Signals
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.005
Glossary
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.012
Negligent Psychopharmacology
Cooke, B. K. (2022) · Springer eBooks · doi:10.1007/978-3-030-91975-7_16
Depression
McMickens, C. L., & Landers, A. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-90350-7_10
Boticarium
Medrano, J. F. F. (2015) · Revista de la Asociación Española de Neuropsiquiatría · doi:10.4321/s0211-57352015000100014
Substance Use Disorders
Srivastava, A. B., Jaffe, S. L., & Gold, M. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-90350-7_15
Index
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.014
Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversionPreprint
Wilk, E. J., Howton, T. C., Fisher, J. L., Oza, V. H., Brownlee, R. T., McPherson, K. C., Cleary, H. L., Yoder, B. K., George, J. F., Mrug, M. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.02.518863
Suicide in Context
Granello, D. H., Granello, P. F., & Juhnke, G. A. (2022) · Oxford University Press eBooks · doi:10.1093/oso/9780190059842.003.0003
Pharmacologic Treatment Options in Functional Illness
Abijay, C. A., & Agan, A. D. (2023) · Springer eBooks · doi:10.1007/978-3-031-12998-8_20
Current Treatments for Pediatric Psychiatric Disorders
Siper, P. M., Trelles, M. P., Kufert, Y., & Grice, D. E. (2025) · doi:10.1093/med/9780197640654.003.0067
Case Studies
Schmaling, K. B., & Kaplan, R. M. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009391733.016
Case Study: Antidepressant Medications
Schmaling, K. B., & Kaplan, R. M. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009391733.020
After the FDA issued warnings about antidepressants, youth suicides rose and mental health care dropped
Soumerai, S. B., & Koppel, R. (2022) · doi:10.64628/aai.wa973mhff
What’s a ‘black box’ warning? A pharmacologist explains how these labels protect patients
White, C. (2025) · doi:10.64628/aai.n67xcxfeh
Antidepressant selection modifies survival in depression: A National Cohort Study Using NHANES 2005 - 2018 data
Zhuang, X., Chen, W., Zhan, Y., Feng, X., & Liu, C. (2025) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2025.12.001
Additional file 3 of Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
Wilk, E. J., Howton, T. C., Fisher, J. L., Oza, V. H., Brownlee, R. T., McPherson, K. C., Cleary, H. L., Yoder, B. K., George, J. F., Mrug, M. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590916
Additional file 2 of Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
Wilk, E. J., Howton, T. C., Fisher, J. L., Oza, V. H., Brownlee, R. T., McPherson, K. C., Cleary, H. L., Yoder, B. K., George, J. F., Mrug, M. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590913
Additional file 1 of Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
Wilk, E. J., Howton, T. C., Fisher, J. L., Oza, V. H., Brownlee, R. T., McPherson, K. C., Cleary, H. L., Yoder, B. K., George, J. F., Mrug, M. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590910
Additional file 4 of Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
Wilk, E. J., Howton, T. C., Fisher, J. L., Oza, V. H., Brownlee, R. T., McPherson, K. C., Cleary, H. L., Yoder, B. K., George, J. F., Mrug, M. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590919
Additional file 5 of Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
Wilk, E. J., Howton, T. C., Fisher, J. L., Oza, V. H., Brownlee, R. T., McPherson, K. C., Cleary, H. L., Yoder, B. K., George, J. F., Mrug, M. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590922
Selective Serotonin Reuptake Inhibitors (SSRIs), Childhood and Adolescent Depression, and Suicidality Following the FDA's 2004 Black Box Warning: A Systematized Literature Review
Kaur, H., & Memon, A. M. (2025) · Cureus · doi:10.7759/cureus.100438
Psychopharmacology
Miller, C. O. G. (2025) · Springer eBooks · doi:10.1007/978-3-032-13315-1_2
Teen Suicide Statistics: Data Informing Suicide Prevention Advocacy
Brock, S. E. (2026) · Contemporary School Psychology · doi:10.1007/s40688-026-00587-6
Depression in Underserved Populations: Primary Care–Based Strategies for Identifying, Assessing, and Treating Depression in Youth
Velez, G. E., Peist, E. A., & Yaqub, T. M. (2026) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610028493-ch15
Dépression et conduites suicidaires
Jaffré, C., & Vinckier, F. (2025) · Elsevier eBooks · doi:10.1016/b978-2-294-78794-2.00018-x
Antidépresseurs et risque suicidaire
Nobile, B. (2025) · Elsevier eBooks · doi:10.1016/b978-2-294-78794-2.00043-9
Suicide and Depression
Kim, T. H., & Nam, B. (2026) · Springer eBooks · doi:10.1007/978-981-92-1331-3_17
Beyond reasonable doubt: antidepressants and the limits of scientific critique
Goulder, J. (2026) · Medical History · doi:10.1017/mdh.2026.10090

Authors: Friedman, R. A.
Affiliations: Cornell University (US)
Corresponding author: Friedman, Richard A.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2014-10-30
Volume: 371
Issue: 18
Pages: 1666-1668
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmp1408480
OpenAlex: W2006985105
Cited by: 171
References: 5
Citations by year: 2026: 7 · 2025: 11 · 2024: 19 · 2023: 11 · 2022: 14 · 2021: 9 · 2020: 15 · 2019: 13 · 2018: 34 · 2017: 14 · 2016: 11 · 2015: 11 · 2014: 1
FWCI: 14.55
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords: antidepressants, black box warning, suicide risk, FDA drug labeling, treatment underuse, depression treatment
MeSH terms: Suicide Prevention, Adolescent, Adult, Aged, Antidepressive Agents, Child, Depressive Disorder, Drug Labeling, Drug Utilization, Humans, Risk Factors, Suicide, United States, United States Food and Drug Administration, Government Regulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antidepressants' Black-Box Warning — 10 Years Later

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks